Cabozantinib in Women With Metastatic Hormone-Receptor-Positive Breast Cancer
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Cabozantinib|DRUG: Fulvestrant
Sponsor: Massachusetts General Hospital
Collaborators: Exelixis